Search results
Forget Mykonos and Santorini, Syros is the best Greek island. Here are 10 of my favorite things to...
INSIDER via Yahoo News· 1 month agoSyros is a charming Greek island near Mykonos. Joanna Kalafatis Syros, a short ferry ride from...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript November 14, 2023...
individual investors who own 35% along with institutions invested in Syros Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Syros Pharmaceuticals' significant individual investors ownership suggests that the key...
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
Zacks via Yahoo Finance· 6 months agoSyros (SYRS) posts encouraging initial data from the phase II SELECT-AML-1 study evaluating...
Syros Pharmaceuticals, Inc. (SYRS) Moves to Strong Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) might move higher on growing optimism about its earnings...
Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 year agoSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 24.11% and 0.14%,...
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look...
Zacks via Yahoo Finance· 1 month agoSyros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a...
Syros (SYRS) Up on FDA's Orphan Tag for Pancreatic Cancer Drug
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals (SYRS) receives Orphan Drug designation from the FDA for its pipeline...
One Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) insider upped their stake by 212% in the previous year
Simply Wall St. via Yahoo Finance· 1 year agoViewing insider transactions for Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS ) over the last year, we...
TYME Technologies Shares Surge On Merger Agreement With Syros Pharma
Benzinga via Yahoo Finance· 2 years agoSyros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME),...